foxo4-dri peptide senolytic animal model 2023 The disordered p53 transactivation domain is the target of FOXO4 and the compound Translating the Biology of Aging
Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics The Journal of Prevention of Alzheimer's Disease Springer Nature Link FOXO4 an overview ScienceDirect Topics The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal
Pay in 4 interest-free payments of $6.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


